Janus kinase 2/signal transducer and activator of transcription 3 (JAK2/STAT3) signaling pathway plays an important role in a variety of cancers, including prostate cancer, hematological malignancies, and liver cancer [23]. This evidence concerns the gene JAK2 and hematologic disorder.